Atlas Trials

Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

RecordFirmDate
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy (NCT05283226)NATCO Pharma Ltd.2022-09-30

Track Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.